Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ridgeback Biotherapeutics
Pharma
Slump of Merck's COVID-19 pill continues with trial failure
Merck reported that its COVID-19 oral antiviral Lagevrio did not significantly reduce the risk of COVID-19 following household exposure to the virus.
Kevin Dunleavy
Feb 21, 2023 10:53am
Emergent to produce Ebola drug Ebanga in U.S. for Ridgeback
Jul 8, 2022 10:22am
Paxlovid usage is ticking up in the US
May 26, 2022 10:40am
ICER's latest cost analysis favors Paxlovid over molnupiravir
May 10, 2022 8:55am
Pfizer's Paxlovid to be on tap for thousands more in the U.K.
Apr 12, 2022 10:12am
U.S. grounds GSK/Vir COVID-19 antibodies in 8 northeast states
Mar 28, 2022 10:20am
